These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Flavonoid and cannabinoid impact on the ocular surface. Bielory L; Tabliago NRA Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):482-492. PubMed ID: 32796166 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye. Mah FS; O'Brien T; Kim T; Torkildsen G Curr Med Res Opin; 2008 Feb; 24(2):441-7. PubMed ID: 18167176 [TBL] [Abstract][Full Text] [Related]
10. [Dry eye syndrome and allergic conjunctivitis--epidemics of XXI century--diagnostic problems and management]. Kubicka-Trzaska A; Romanowska-Dixon B Przegl Lek; 2009; 66(11):967-71. PubMed ID: 20297640 [TBL] [Abstract][Full Text] [Related]
14. [Use of cyclosporine 0.05% in various ocular surface disorders]. Maĭchuk DIu; Vasil'eva OA; Shokirova MM Vestn Oftalmol; 2014; 130(2):68-71. PubMed ID: 24864503 [TBL] [Abstract][Full Text] [Related]
15. Quercetin as a Lyn kinase inhibitor inhibits IgE-mediated allergic conjunctivitis. Ding Y; Li C; Zhang Y; Ma P; Zhao T; Che D; Cao J; Wang J; Liu R; Zhang T; He L Food Chem Toxicol; 2020 Jan; 135():110924. PubMed ID: 31672514 [TBL] [Abstract][Full Text] [Related]
16. Chemokines: roles in leukocyte development, trafficking, and effector function. Ono SJ; Nakamura T; Miyazaki D; Ohbayashi M; Dawson M; Toda M J Allergy Clin Immunol; 2003 Jun; 111(6):1185-99; quiz 1200. PubMed ID: 12789214 [TBL] [Abstract][Full Text] [Related]
17. The anti-inflammatory effects of therapies for ocular allergy. Mantelli F; Calder VL; Bonini S J Ocul Pharmacol Ther; 2013 Nov; 29(9):786-93. PubMed ID: 24044620 [TBL] [Abstract][Full Text] [Related]